losartan has been researched along with phenol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Strassburg, CP; Tukey, RH | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Meanwell, NA | 1 |
Goda, M; Hobara, N; Kawasaki, H; Kitamura, Y; Mio, M; Takatori, S; Yoshida, N | 1 |
Goda, M; Hashikawa, N; Hobara, N; Kawasaki, H; Yoshida, N | 1 |
2 review(s) available for losartan and phenol
Article | Year |
---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
[Regeneration of perivascular nerve and role of angiotensin receptors].
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcitonin Gene-Related Peptide; Humans; Imidazoles; Losartan; Male; Mesenteric Arteries; Nerve Growth Factor; Nerve Regeneration; Neuropeptide Y; Peripheral Nerve Injuries; Peripheral Nerves; Phenol; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Stimulation, Chemical | 2010 |
3 other study(ies) available for losartan and phenol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synopsis of some recent tactical application of bioisosteres in drug design.
Topics: Cytochrome P-450 Enzyme System; Drug Design | 2011 |
Angiotensin II type 2 receptors facilitate reinnervation of phenol-lesioned vascular calcitonin gene-related peptide-containing nerves in rat mesenteric arteries.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blotting, Western; Calcitonin Gene-Related Peptide; Enteric Nervous System; Ganglia, Spinal; Imidazoles; Losartan; Mesenteric Artery, Superior; Nerve Fibers; Nerve Growth Factor; Nerve Regeneration; Neuropeptide Y; Norepinephrine; Phenol; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 2; Sclerosing Solutions; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2007 |